Purchases and Sales Made in Q2 2023 in Paratek Pharmaceuticals, Inc. (PRTK)
This table provides information about the institutional ownership of Paratek Pharmaceuticals, Inc. (PRTK) during Q2 2023. The information is specifically focused on institutions that hold shares of Paratek Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Jul 31, 2023
Q2 2023
|
Lpl Financial LLC
Fort Mill, SC |
SELL
|
- |
-41.3K- 79.59% |
$62.8K - $116K
|
10.6K
$0
|
|
Aug 03, 2023
Q2 2023
|
General American Investors CO Inc
|
SELL
|
- |
-75K- 3.92% |
$114K - $210K
|
1.84M
$0
|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-113K- 46.51% |
$171K - $315K
|
130K
$0
|
|
Aug 14, 2023
Q2 2023
|
J. Goldman & CO LP
New York, NY |
SELL
|
- |
-157K- 17.16% |
$239K - $440K
|
758K
$0
|
|
Aug 11, 2023
Q2 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-172K- 16.13% |
$262K - $482K
|
895K
$0
|
|
Aug 04, 2023
Q2 2023
|
Cm Management, LLC
|
SELL
|
- |
-200K- 44.44% |
$304K - $560K
|
250K
$0
|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-205K- 64.83% |
$312K - $575K
|
111K
$0
|